What the 2025–2026 COVID-19 Vaccine Recommendations Mean for Your Immune System

Why updated COVID-19 vaccines matter in 2025–2026

Practical takeaway: Updated COVID-19 vaccines are designed to better match the variants currently circulating in the United States and to refresh your immune protection—especially against severe illness.

COVID-19 has not disappeared. While hospitalizations are lower than during earlier waves, the virus continues to evolve. The Centers for Disease Control and Prevention (CDC) recommends staying up to date with the 2025–2026 COVID-19 vaccine to reduce your risk of hospitalization and death.

For most people, protection against mild infection fades over time. Protection against severe disease lasts longer—but it also benefits from an updated dose. That’s why federal health agencies review the vaccine formula each year.

How the FDA and CDC decide on strain updates

Each year, the Food and Drug Administration (FDA) reviews data on which variants are circulating in the U.S. and globally. The agency considers:

Variant prevalence data from CDC surveillance
Laboratory studies showing how well antibodies from prior vaccination neutralize newer strains
Real-world vaccine effectiveness data
Input from independent advisory committees

Based on that review, the FDA selects a strain (or lineage) to target in the updated vaccine. Manufacturers then produce monovalent vaccines designed to more closely match the dominant variant family.

The CDC’s Advisory Committee on Immunization Practices (ACIP) reviews safety and effectiveness data and makes recommendations about who should receive the updated vaccine and how many doses are advised.

This is similar in concept to how influenza vaccines are updated, although COVID-19 recommendations can change if new data emerge.

How your immune system responds: antibodies, memory cells, and waning protection

When you receive an updated COVID-19 vaccine, your immune system responds in layers.

Antibodies are proteins that circulate in your blood and help block the virus from infecting cells. These tend to rise quickly after vaccination—but they also decline over months. That’s one reason protection against mild infection can decrease over time.

Memory B cells and T cells are longer-lasting immune cells. Memory B cells can quickly produce new antibodies if you’re exposed again. T cells help destroy infected cells and limit severe damage.

This immune memory is why vaccines generally provide stronger and more durable protection against hospitalization and death than against mild or asymptomatic infection.

Still, immune durability varies by age, health status, prior infection history, and time since the last dose. Older adults and people with weakened immune systems often mount a less robust response and may need additional doses to maintain protection.

What the latest CDC data show about protection against hospitalization

Recent CDC analyses published in MMWR (Morbidity and Mortality Weekly Report) have evaluated how well updated vaccines protect against severe outcomes. Most of these studies are observational—meaning researchers analyze real-world data rather than conducting randomized trials.

Across multiple reports, updated COVID-19 vaccines have been associated with a meaningful reduction in the risk of hospitalization and critical illness compared with not being vaccinated or being further out from a prior dose.

However, observational studies have limitations:

People who choose vaccination may differ from those who do not (health behaviors, underlying conditions).
Prior infection can influence immune protection.
Circulating variants change over time.

Even with those limitations, CDC data consistently show stronger protection against severe disease than against mild infection. Protection is highest in the first few months after vaccination and gradually declines.

The CDC COVID Data Tracker continues to monitor variant trends and hospitalization patterns nationwide.

Who should get vaccinated now — and how many doses

According to current CDC guidance for the 2025–2026 season:

Everyone ages 6 months and older is recommended to receive the updated COVID-19 vaccine.
Adults ages 65 and older may be advised to receive an additional dose several months after their first updated dose to strengthen protection.
People who are moderately or severely immunocompromised may need additional doses and individualized timing, based on CDC guidance and clinical judgment.

The Infectious Diseases Society of America (IDSA) notes that immunocompromised patients may have reduced vaccine responses and benefit from tailored schedules and early access to antiviral treatment if infected.

Guidance can change as new data emerge, so it’s worth checking the CDC’s “Stay Up to Date” page or speaking with your healthcare provider.

Practical questions: timing with flu shots, coverage, and access

Can you get COVID-19 and flu shots at the same visit?
Yes. The CDC says COVID-19 vaccines can be given at the same time as influenza vaccines, in different arms. Some people prefer spacing them by a week or two to monitor side effects, but coadministration is considered safe.

Will insurance cover it?
Most private insurance plans cover ACIP-recommended vaccines without cost-sharing. Medicare Part B covers COVID-19 vaccines. Medicaid and most state programs also cover recommended doses. If you are uninsured, local health departments or community clinics may offer low- or no-cost options.

When is the best time?
For many people, fall vaccination aligns with respiratory virus season. High-risk individuals may consider timing doses ahead of travel or anticipated exposure.

When to seek care — and why early treatment still matters

Vaccination reduces your risk of severe illness, but it does not eliminate it.

Seek medical care promptly if you experience:

Shortness of breath
Chest pain
Confusion
Persistent high fever
Low oxygen readings (if you monitor at home)

Adults 65 and older, pregnant people, and individuals with chronic medical conditions or weakened immune systems should contact a healthcare provider quickly if they test positive. Antiviral treatments such as nirmatrelvir-ritonavir (Paxlovid) or remdesivir work best when started early.

What this means for your immune system

Updated COVID-19 vaccines in 2025–2026 are meant to do two things: better match circulating variants and refresh immune protection that naturally fades over time.

Antibody levels decline, but immune memory helps maintain protection against severe disease. Still, older adults and immunocompromised individuals may need additional doses to maintain stronger protection.

The bottom line: staying up to date is less about preventing every infection and more about reducing your risk of hospitalization, complications, and death. For most people, that remains the central goal of COVID-19 vaccination policy in the United States.

Sources

This article is for general informational purposes only and is not medical advice. Research findings can be early, limited, or subject to change as new evidence emerges. For personal guidance, diagnosis, or treatment, consult a licensed clinician. For current outbreak or public health guidance, follow your local health department, the CDC, or another relevant public health authority.